Business Wire23m
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Bellingham completed its lead pipe audit. Should you be concerned about your drinking water?
The U.S. Environmental Protection Agency (EPA) published Lead and Copper Rule Long-Term Revisions in 2021, requiring all ...